At a glance
ClinicalIndex Comparison RecordN/ACompleted· 82 enrolled
Drug / intervention
3M Coban 2 (Compression System) +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Preliminary Study to Assess the Effectiveness of 3M Oedema Reduction System in the Treatment of Lymphoedema Treatment Compared to Comprilan Short-stretch Bandage Compression Therapy
In Brief
A clinical study evaluating 3M Coban 2 (Compression System) and Comprilan for Lymphedema. Completed, enrolled 82 participants across 11 sites in 2 countries.
Detailed Summary
Objectives. The primary objective of the study is to assess volume reduction in the treatment of lymphoedematous legs and arms with compression bandaging. Secondary objectives: * Assessment of safety * Quality of life * Health economic parameters * Slippage * Subbandage pressure
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphedema
CountriesUnited Kingdom, United States
Collaborators3M
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
First PostedMar 2010
Primary CompletionOct 2010
TodayJul 2026
First PostedMar 31, 2010
Enrollment StartMar 1, 2010
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 16.3 years ago
Interventions
3M Coban 2 (Compression System)device
Nonwoven cohesive backing and foam.
3M Coban 2 (Compression System)device
Nonwoven cohesive backing and foam.
3M Coban 2 (Compression System)device
Nonwoven cohesive backing and foam.
Comprilandevice
Commercial short-stretch bandage (Comprilan; BSN Medical Ltd, Hull, U.K).